MediLexicon Logo
MediLexicon Logo
Abbreviations        Abbrev Definitions        Dictionary        ICD Codes        Equipment        Hospitals        Drugs        More..
  
urology and nephrology image

Urology & Kidney Drugs

Prescription drugs and medicines for conditions and diseases relating to the kidneys and the urinary tract. Studies in these areas include: bladder cancer, impotence, kidney disease, kidney stones, mastectomy, nocturia, renal cell carcinoma, urinary tract infections, and others.

The list of FDA approved drugs for urology and nephrology appears below. Click any link to view the full drug information.


Bookmark and Share
Number Of Urology & Kidney Drugs: 77

Afinitor (everolimus)
For the treatment of renal cell carcinoma
Afinitor (everolimus)
For the treatment of renal angiomyolipoma associated with tuberous sclerosis complex
Anturol (oxybutynin) Gel
For the treatment of overactive bladder
Avastin (bevacizumab)
For the treatment of renal cell carcinoma
Carbaglu (carglumic acid)
For the treatment of hyperammonemia
Caverject (alprostadil)
Treatment for impotence
Cefazolin and Dextrose USP
Respiratory tract infections
Cipro (ciprofloxacin HCl)
Treatment for cystitis
Degarelix (degarelix for injection)
For the treatment of prostate cancer
Detrol (tolterodine tartrate)
Treatment for an overactive bladder
Detrol LA (tolterodine tartrate)
For the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and frequency
Ditropan XL (oxybutynin chloride)
Treatment for overactive bladder
Ditropan XL (oxybutynin chloride)
Treatment for and Overactive Bladder
Doribax (doripenem)
For the treatment of intra-abdominal infections and urinary tract infections
Dutasteride
For the treatment of symptomatic benign prostatic hyperplasia
EDEX
Treatment for erectile dysfunction
Eligard (leuprolide acetate)
For the palliative treatment of advanced prostate cancer
Elmiron (pentosan polysulfate sodium)
Treatment for interstitial cystitis
Eulexin (flutamide)
Treatment for prostate cancer
Fabrazyme (agalsidase beta)
For the treatment of Fabry disease in adult patients
Feraheme (ferumoxytol)
For the treatment of iron deficiency anemia associated with chronic kidney disease
FLOMAX
Treatment for benign prostatic hypertrophy (BPH)
Fosrenol, lanthanum carbonate
For the treatment of hyperphosphatemia related to kidney dysfunction
Gelnique (oxybutynin chloride)
For the treatment of overactive bladder
Gemzar (gemcitabine HCL)
Treatment for pancreatic cancer
Hectorol (Doxercalciferol) Injection
To reduce iPTH levels in management of secondary hyperparathyroidism in patients undergoing chronic renal dialysis
Injectafer (ferric carboxymaltose injection)
For the treatment of iron deficiency anemia
Inlyta (axitinib)
For the treatment of advanced renal cell carcinoma
Interstim Continence Control Therapy
Treatment for incontinence
Invanz
Once-daily injectable treatment for bacterial infections
Jalyn (dutasteride + tamsulosin)
For the treatment of benign prostatic hyperplasia
Jevtana (cabazitaxel)
For the treatment of prostate cancer
Levaquin
Treatment for urinary tract infection
Lupron Depot (leuprolide acetate for depot suspension)
Treatment for advanced prostate cancer
Mesnex
Oral tablet to inhibit the hemorrhagic cystitis induced by Ifex (ifosfamide)
Mircera (methoxy polyethylene glycol-epoetin beta)
For the treatment of anemia associated with chronic renal failure
Monurol
Treatment for uncomplicated urinary tract infection
Myrbetriq (mirabegron)
For the treatment of overactive bladder
Nascobal Gel (Cyanocobalamin, USP)
Treatment for vitamin B-12 deficiency
Nulojix (belatacept)
For the prevention of organ rejection following kidney transplant
Omontys (peginesatide)
For the treatment of anemia due to chronic kidney disease
Oxytrol (oxybutynin transdermal system)
For the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency.
PhosLo
Oral capsules and gelcaps for the control of hyperphosphatemia in end stage renal failure
Procysbi (cysteamine bitartrate)
For the management of nephropathic cystinosis
Prograf
Treatment for the prevention of kidney transplant rejection
Proscar
Treatment for complication relating to benign prostatic hyperplasia (BPH)
Provenge (sipuleucel-T)
For the treatment of hormone refractory prostate cancer
Rapamune (sirolimus) Tablets
For treatment of kidney rejection
Renagel (sevelamer hydrochloride)
For the control of serum phosphorus in patients with chronic kidney disease on dialysis
Renagel (sevelamer hydrochloride)
For the reduction of serum phosphorus in patients with end-stage renal disease (ESRD)
RenaGelRenagel (sevelamer hydrochloride)
Treatment for Renal Disease
Renvela (sevelamer carbonate)
For the control of serum phosphorus in patients with chronic kidney disease on dialysis
Sanctura (trospium chloride)
For the treatment of overactive bladder with symptoms of urge urinary incontinence
Sensipar (cinacalcet)
For the treatment of secondary hyperparathyroidism and hypercalcemia in parathyroid carcinoma patients
Seprafilm
Treatment for the reduction of scar tissue as a result of abdominal or pelvic surgery
Simulect
Treatment for acute organ transplant rejection
Soliris (eculizumab)
For the treatment of atypical hemolytic uremic syndrome
Stendra (avanafil)
For the treatment of erectile dysfunction
Stivarga (regorafenib)
For the treatment of previously treated patients with metastatic colorectal cancer
Tequin
Tequin (Injectable and Tablet)
Torisel (temsirolimus)
For the treatment of renal cell carcinoma
Toviaz (fesoterodine fumarate)
For the treatment of overactive bladder
Trelstar Depot (triptorelin pamoate)
For the palliative treatment of advanced prostate cancer
Trelstar LA (triptorelin pamoate)
Intramuscular injection for the treatment of advanced stage prostate cancer
UroXatral (alfuzosin HCl extended-release tablets)
For the treatment of of the signs and symptoms of benign prostatic hyperplasia
Vaprisol (conivaptan)
For the treatment of euvolemic hyponatremia
Venofer (iron sucrose injection)
For the treatment of iron deficiency anemia in patients undergoing chronic hemodialysis
Vesicare (solifenacin succinate)
For the treatment of overactive bladder with symptoms of urge urinary incontinence
Viadur (leuprolide acetate implant)
For pain relief in men with advanced prostate cancer
Visipaque (iodixanol)
Diagnostic contrast agent
Voraxaze (glucarpidase)
For the treatment of toxic plasma methotrexate concentrations in patients with impaired renal function
Votrient (pazopanib)
For the treatment of renal cell carcinoma
Xifaxan (rifaximin)
For the treatment of hepatic encephalopathy
Zemplar
Treatment of secondary hyperparathyroidism associated with chronic renal failure
Zenapax
Treatment to prevent rejection of kidney transplants
Zoladex (10.8 mg goserelin acetate implant)
Treatment for advanced prostate cancer
Zortress (everolimus)
For the prevention of organ rejection following kidney transplant


« back to top
FDA Approved Urology & Kidney Drugs Listings:

The rules of principle for evaluating MediLexicon's FDA urology & kidney drugs listings adhere to the FDA definitions of a new drug approval or a new molecular entity, and the Tufts Center for the Study of Drug Development.

MediLexicon's FDA Approved Drugs Listings include:

New Molecular Entities (NME): these NME's are described as a medication containing an active substance that have never previously approved in the US for marketing in any manner, shape or form (as defined by the FDA). In addition to this, there is also the inclusion of some FDA's Center for Drug Evaluation and Research (CDER) approved recombinant proteins and biologics.

MediLexicon's FDA Approved Drugs Listings do NOT include:

Over-the-counter products, diagnostic agents, generics, most vaccines, medical devices, biologic compounds (not approved by CDER), as well as new indications and new administrations of previously-approved compounds and new dosages.

The urology & kidney drugs information used in this section is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.









MediLexicon International Ltd Logo

Privacy Policy   |    Disclaimer   |    Contact / Feedback

MediLexicon International Ltd
Bexhill-on-Sea, UK
MediLexicon International Ltd © 2004-2014 All rights reserved.